Date published: 2025-9-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

CENP-F Inhibitors

The class of chemicals known as CENP-F Inhibitors encompasses a diverse group of molecules that share the functional consequence of inhibiting the activity of Centromere protein F (CENP-F), a key component involved in the regulation of mitosis and proper chromosome alignment and segregation. These inhibitors operate through various mechanisms, often targeting the regulatory pathways and protein interactions that modulate the stability, localization, and function of CENP-F within the cell cycle. Some of these compounds are known to intervene in kinase signaling pathways or disrupt the transcription factors that control the expression levels of CENP-F, thereby indirectly leading to its inhibition. By altering the kinase activity, for instance, that of Aurora A kinase, which is essential for mitotic entry and spindle assembly, these inhibitors can reduce the recruitment or activity of CENP-F at the kinetochores.

In addition to kinase inhibition, other chemicals within this class may interfere with motor proteins and microtubule dynamics, which are crucial for the proper function of CENP-F during cell division. Inhibitors like Monastrol, which targets the Eg5 kinesin motor protein, lead to defects in spindle assembly and as a consequence, can attenuate the function of CENP-F. These inhibitors may also engage with various checkpoints throughout the cell cycle, for example, by inhibiting Mps1/TTK kinase and thus affecting the spindle assembly checkpoint, possibly causing a reduction in CENP-F's role in this process

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

A thiazole antibiotic that inhibits FOXM1, a transcription factor involved in cell cycle regulation which can downregulate CENP-F.

Thiostrepton

1393-48-2sc-203412
sc-203412A
1 g
5 g
$115.00
$415.00
10
(1)

Interferes with FOXM1 transcriptional activity, potentially reducing CENP-F expression associated with mitotic spindle assembly.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

Inhibits Aurora A kinase, which is necessary for proper spindle assembly and kinetochore function, possibly decreasing CENP-F function.

Monastrol

254753-54-3sc-202710
sc-202710A
1 mg
5 mg
$120.00
$233.00
10
(1)

Inhibits Eg5 kinesin motor protein, leading to spindle assembly defects which may reduce the necessity for CENP-F in cell cycle progression.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

A CDK4/6 inhibitor that leads to G1 arrest, potentially downregulating CENP-F which is not needed outside of mitosis.

Griseofulvin

126-07-8sc-202171A
sc-202171
sc-202171B
5 mg
25 mg
100 mg
$83.00
$216.00
$586.00
4
(2)

Disrupts microtubule function, potentially diminishing the requirement for CENP-F in mitotic progression.

S-Trityl-L-cysteine

2799-07-7sc-202799
sc-202799A
1 g
5 g
$31.00
$65.00
6
(1)

A reversible inhibitor of Eg5 that impairs mitotic spindle function, potentially reducing the recruitment of CENP-F to kinetochores.

AZ 3146

1124329-14-1sc-361114
sc-361114A
10 mg
50 mg
$214.00
$887.00
7
(1)

Inhibits Monopolar spindle 1 (Mps1/TTK) kinase, possibly disrupting CENP-F's role in the spindle assembly checkpoint.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), could impact cell cycle regulation and indirectly decrease CENP-F activity.

Purvalanol B

212844-54-7sc-361300
sc-361300A
10 mg
50 mg
$199.00
$846.00
(1)

Inhibits cyclin-dependent kinases and could lead to cell cycle arrest, potentially downregulating CENP-F.